Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
33%
Analgesic Agent
33%
Anandamide
33%
Cannabinoid
66%
Cannabinoid 2 Receptor
41%
Cannabinoid Receptor
100%
Cannabis Sativa
41%
Chronic Pain
33%
Drug Development
33%
G Protein Coupled Receptor
33%
Ion Channel
33%
Loss of Appetite
41%
Mutagenesis
33%
Opiate
33%
Pain
41%
Pseudoephedrine Plus Triprolidine
41%
Side Effect
33%
Symptom
33%
Transient Receptor Potential Channel
83%
Vanilloid Receptor
41%
Vanilloids
41%
Keyphrases
Abuse Risk
9%
Alzheimer's Disease
6%
Analgesic Effect
6%
Anandamide
6%
Appetite Loss
9%
Atomic Level
6%
Calcium-dependent
6%
Cannabinoid Ligands
21%
Cannabinoid Receptor 1 (CB1R)
66%
Cannabis Sativa
9%
Capsaicin Receptor
9%
CB2 Receptor
9%
Chronic Pain Syndrome
9%
Computational Techniques
6%
Dependent Processes
9%
Epilepsy Treatment
6%
Grant Applications
6%
Ion Channels
6%
Ionotropic
100%
Level Description
9%
Live-cell Calcium Imaging
6%
Model Dynamics
6%
Molecular Dynamics Simulation
6%
Mutagenesis
6%
Nervous System
6%
Opioid Treatment
6%
Pain Perception
6%
Painful Stimuli
6%
Polymodal
9%
Rational Drug Design
6%
Relieve Pain
9%
Safe Treatment
9%
Therapeutic Potential
6%
Transient Receptor Potential Vanilloid 1 (TRPV1)
100%
Treatment Options
6%
TRP Channels
18%
Unwanted Side Effects
9%
Vanilloid
9%